webinar register page

COVID-19 and Diabetes Congressional Briefing
Over the last 12 months, the COVID-19 pandemic has created many new challenges and questions related to its impact on people with diabetes, including:
• Whether COVID-19 exposes or contributes to new onset diabetes
• The occurrence of post-acute COVID-19 syndrome
• COVID-19 outcomes for various racial and ethnic groups
• How to prevent death and long-term disability from SARS-CoV-2 infection and improve treatment for COVID-19 for people with diabetes, including those in communities that suffer from health disparities

Please join us for a virtual briefing to learn more about COVID-19 and diabetes featuring:
o Representative Kim Schrier (WA-08)
o Griffin P. Rodgers, MD, MACP, Director of the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health
o Joshua J. Joseph, MD, MPH, FAHA, Assistant Professor of Medicine, The Ohio State University Wexner Medical Center
o Mary Korytkowski MD, Professor of Medicine, University of Pittsburgh

Q&A with panel and William Cefalu, MD, Director of the Division of Diabetes, Endocrinology and Metabolic Diseases, NIDDK moderated by Robert Lash, MD, Acting CEO and Chief Medical Officer of the Endocrine Society.

Mar 31, 2021 12:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Endocrine Webinars.